Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith–Lemli–Opitz syndrome

Clinical effects of cholesterol suppleme

Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)

✍ Elias, Ellen R.; Irons, Mira B.; Hurley, Anne D.; Tint, G. Stephen; Salen, Geral 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

We describe the clinical effects of cholesterol supplementation in 6 children with the RSH-"Smith-Lemli-Opitz" syndrome (SLOS). The children ranged in age from birth to 11 years at the onset of therapy, with pretreatment cholesterol levels ranging from 8 to 62 mg/dl. Clinical benefits of therapy wer